The UK’s first fully-licensed EU-GMP medical cannabis cultivation facility has opened its doors to doctors,
Since the legalisation of medical cannabis in the UK in 2018, its integration into mainstream
Written by: Releaf’s Clinical Dr Alex Van Heerden After years prescribing opioids, Dr Alexander Van
Researchers from Brazil have published a detailed study showing significant improvements in a patient living
A recent YouGov poll, asking the British public their views on cannabis reform compared to
At PatientsCann UK, we are deeply concerned by Network Rail’s recently issued safety advice (NRA24-13), which imposes a blanket ban
The post Network Rail’s Medical Cannabis Policy: A Cause for Concern first appeared on PatientsCann UK.
Via Business of Cannabis In a long-awaited and major step forward for the UK’s CBD
The legal dispensing of cannabis via a cultivation association has taken place for the first
Six years on from the legalisation of medical cannabis in the UK, families have made
A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re
A study has found that a single high dose of psilocybin can lead to physical
Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the
The number of items prescribed in the UK’s private medical cannabis market has doubled each
Product Earth, the UK’s largest event celebrating cannabis and other natural medicines, has cancelled the
Landlords, property managers, and housing associations in the UK are currently at risk of breaching
Written by Releaf Releaf offers every patient at the clinic a medical cannabis card to
Introduction: The Life of a CAPEX Director As the Director of Capital Projects (CAPEX) for investors based in Geneva, my professional journey took me to Africa, South Asia, and the Middle East. My work involved extensive travel to various “hot spots,” which left me returning home to England only when possible. This lifestyle eventually took […]
The post From CAPEX Director to Cannabis Advocate: A Journey of Resilience and Healing appeared first on I Am Billy.
In what was thought to be a first for a major mainstream health conference on
A new animal study has highlighted the possible benefits of CBD and the diabetes drug,
Cannabis, once stigmatized and criminalized, has emerged as a powerful medicinal substance. With growing research and changing perceptions, the therapeutic potential of cannabis is becoming widely recognized. This blog explores the transformative role of cannabis in modern medicine, highlighting its benefits, applications, and the science behind its efficacy. A Brief History of Cannabis in Medicine […]
The post The Power of Cannabis as Medicine appeared first on I Am Billy.
JuicyFields crowd growing platform Vs. Canadian cannabis market: Overview of two medicinal cannabis hype cases with totally different approaches and outcomes. Sponsored post Despite a loud joyful boom that happened in Canada in 2019 when cannabis was moved to the legal side, the country has failed
A 20-year US study points to major shifts in teenage substance use trends, with alcohol abuse declining while the consumption of cannabis edibles climbs. Adolescent cannabis abuse has increased 245% since 2000 in the US, according to a new study, while alcohol abuse has steadily declined
New findings, showing that cannabinoids may interfere with peanut allergies, could pave the way for new treatments. Researchers say a new study, examining the effects of cannabinoids on peanut sensitivity, could pave the way for the development of new treatments targeting the allergy. They investigated
Medical Cannabis Awareness Week is set to take place again as the UK marks the fifth anniversary of the landmark law change in November 2018. Originally launched by patient advocacy group PLEA (Patient-Led Engagement for Access) in 2020, Medical Cannabis Awareness Week (MCAW) will take place
The success of reputable cannabis and CBD brands has inspired an influx of inexperienced and disreputable competitors in the market. These so-called “bad actors” in CBD advertise products that are not manufactured under current Good Manufacturing Practices (cGMP), which help to ensure that all products are
Results of a survey with 1087 participants show that cannabis use may be associated with spiritual benefits. The study was conducted by investigators of the California School of Professional Psychology at Alliant International University in Emeryville, USA. Spiritual benefit from cannabis was reported by 66.1% of
Launched in 2019, leafie is an online magazine focusing on the changing world of cannabis and psychedelics. We mix educational, topical and entertainment-focused content to meet the growing demand for information on these substances, as they shed their stigma and become tools for improved living. We
Classic psychedelics such as LSD, psilocybin and ayahuasca could be effective as a treatment for alcohol use disorder (AUD), according to two recently published studies. In the first open-label study, which is yet to be peer-reviewed, researchers at the University of Copenhagen and the National Institute
A pilot cannabis legalisation trial in Zurich, Switzerland is producing positive results, according to a press release from the city’s Health and Environment Department. Residents of Zurich participating in the trial have been able to legally purchase cannabis flower and extracts containing THC from approved sources
A study of data published in the journal Drug and Alcohol Dependence has found that cannabis legalisation in Canada has led to a reduction in retail sales of beer. Researchers examined alcohol retail data in Canada from 2012 to 2020 to understand the changes in the
A cross-sectional survey of serving police officers has found that over one in four respondents were unaware that cannabis can be prescribed legally in the UK. The survey, conducted between 24 October and 1 November 2022, was designed by a multi-disciplinary team of academic clinicians and
The world is currently witnessing a huge loss of species, some have dubbed it the ‘sixth mass extinction’ due to the speed at which we are seeing fauna and flora, that had previously survived for millennia, being assigned to the history books. Scientists don’t know how
The Irish Health Service Executive (HSE) has announced that the first cannabis-based products will be available through the Medical Cannabis Access Programme from next month. In a joint committee meeting held on Wednesday 29 September, CannEpil was announced as the first drug to be made available
As the cannabis industry experiences a significant shift toward general acceptance and mainstream adoption, new modes of operation are popping up everywhere. The evolution and expansion of the industry beg for constant innovation, and the integration of NFTs and cryptocurrencies as payment options is at the
Introduction to the Cannabis Conundrum The UK’s cannabis industry, especially in the realm of medicinal use, has seen significant growth and attention in recent years. However, beneath the surface of this burgeoning sector lies a complex web of corruption involving cannabis lobbyists, patient organizations, and industry councils. This blog aims to expose the misleading narratives […]
The post Green Shadows: Unmasking the Corruption in Cannabis Lobbying in the UK appeared first on I Am Billy.
A study has shown that essential hemp oil can successfully shrink cancerous lung tumours in mice and reduce chemotherapy-induced neuropathic pain, highlighting the anti-tumour properties of the cannabis plant. Researchers at the China State Institute of Pharmaceutical Industry in Shanghai used an extraction technique to produce
The Sanskara Platform (now PatientsCann UK) and Seed Our Future Co-Author Report with Cannabis Industry Council Urging Employers to Support Prescription Cannabis Patients 07/11/2023 – The Sanskara Platform, in collaboration with Seed Our Future, is pleased to announce the release of an important report addressing the rights of prescription cannabis patients in the workplace. This ground-breaking report, titled ‘The Use of Prescription Cannabis at Work,’ has been authored by Mohammad I Wasway, Founder of The Sanskara Platform, and Guy Coxall, Founder of Seed Our Future. It forms a crucial part of the Standards Working Group within the Cannabis Industry Council (CIC). The report, highlighted by the CIC, reveals a pressing issue affecting prescription cannabis patients and their rights in the workplace. It suggests that current employer practices may put them at risk of breaching the Equality Act. The Act mandates that employers must make reasonable adjustments to accommodate individuals with disabilities, which includes many prescription cannabis patients who often suffer from chronic pain and disabilities. The CIC’s report underscores the necessity for employers to treat prescription cannabis patients just like any other medical patients, aligning with their legal obligations under the Equality Act 2010 and the Health and Safety at Work Act 1974. Report co-authors, Mohammad Wasway and Guy Coxall, expressed their concerns, stating, “We have heard from many concerned and vulnerable patients who have been harassed and mistreated by their employers simply for taking their prescription medication. We urge businesses to support their employees and implement sensible and proportionate solutions that will improve employee wellbeing and productivity.” Elisabetta Faenza, Chair of the CIC Standards Working Group, emphasised the Council’s commitment to upholding workplace rights for prescription cannabis patients, asserting, “The Cannabis Industry Council will be working with employers and unions to uphold workplace rights for prescription cannabis patients, based on law, medicine, and basic compassion. Many businesses say they are committed to equality, diversity, and inclusivity, yet often underdeliver. Now is the time for employers to step up and support ill and disabled employees.” The report not only sheds light on the medical context surrounding prescription cannabis but also suggests ways to manage its usage by employees. It includes user-friendly flowcharts and illustrative case studies to help employers navigate this complex issue. Since 2018, specialist doctors have had the authority to prescribe cannabis medicines to their patients, who are then legally permitted to possess and consume this medication. Employers who fail to uphold the workplace rights of patients, including both employees and job applicants, face the risk of being taken to an employment tribunal. This report is a significant step towards ensuring that prescription cannabis patients receive fair treatment and protection under the law. It calls upon employers to support their employees’ medical needs and uphold the principles of equality, diversity, and inclusivity in the workplace. Read the report here
The post Use of Prescription Cannabis at Work first appeared on PatientsCann UK.
HUGE Gorilla explains why a healthy outside starts from the inside especially when it comes to sports nutrition and busy lifestyles. HUGE Gorilla is quickly establishing itself as a market-leading brand for health and sports nutrition on the go. The best tasting all-natural plant-based vegan fitness
New research has been released for patients with Fibromyalgia which has assessed the effects seen in UK patients after being prescribed medical cannabis. Symptoms commonly experienced in Fibromyalgia include anxiety, debilitating fatigue, chronic pain, sensitivity to light, sound, temperature and touch, as well as cognitive symptoms
Dravet Syndrome is a rare childhood epilepsy syndrome that is commonly associated with treatment-resistant epilepsy, despite best medical treatment. It is estimated that one in 15,700 children will be diagnosed with the condition, most of which will experience seizures in their first year of life. The
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do
Medical cannabis has been available for prescription in the UK since November 2018, and since then an ever-growing number of patients have been able to access these medicines. Now, the UK has approved three vaporisers for the medical use of cannabis, offering specialists doctors the ability
Six years ago today, the UK took a step forward, allowing eligible patients to access medical cannabis for chronic physical and mental health conditions. This November, we celebrate the anniversary of this landmark decision and reflect on the journey so far. Tens of thousands of patients
What is the Care Quality Commission (CQC)? The Care Quality Commission (CQC) is the UK’s independent regulator of health and social care services. It exists to ensure that clinics, hospitals, and other healthcare providers are following all relevant guidelines and meet essential standards of safety, effectiveness,
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
